URMC: For chronic leukemia patients, the news just got even better
STAFF REPORTS ROCHESTER, N.Y. — Several chronic lymphocytic leukemia (CLL) patients at the Wilmot Cancer Institute took part in two groundbreaking, nationwide phase 3 studies that are changing the way…